The Western Europe magnetic resonance imaging (MRI) systems market size is expected to reach US$ 5,336.2 million by 2031 from US$ 3,860.7 million in 2024. The market is estimated to record a CAGR of 4.7% from 2025 to 2031.
Western Europe is one of the dominant regions of the global MRI systems market, characterized by its mature healthcare systems, high technological standards, and universal health coverage in many countries. The market is supported by well-established hospital networks and a significant number of private diagnostic imaging centers. A key factor driving demand is the high and growing prevalence of chronic diseases, particularly cardiovascular conditions, neurological disorders, and cancer, which are major causes of mortality and morbidity in the region. The focus on early diagnosis and preventive healthcare, often supported by public health policies, ensures a consistent need for advanced imaging.
The region is also at the forefront of adopting cutting-edge medical technologies. Healthcare providers in Western Europe are increasingly investing in next-generation MRI systems, including hybrid modalities that combine MRI with PET or other imaging techniques, to improve diagnostic precision. This trend is driven by a focus on enhancing clinical outcomes, reducing the need for invasive procedures, and improving the patient’s experience. The presence of major medical device manufacturers with strong research and development capabilities in the region further accelerates the commercialization and adoption of new innovations.
Western Europe Magnetic Resonance Imaging (MRI) Systems Market Segmentation Analysis:
Key segments that contributed to the derivation of the magnetic resonance imaging (MRI) systems market analysis are type, field strength, mobility, application, and end user.
The Western European MRI systems market is set for sustained growth, with a key driver being the technological advancements in MRI systems, particularly the integration of artificial intelligence (AI) and the development of high-field scanners. AI-powered software is increasingly being used to optimize MRI workflow, reduce scan times, and enhance image quality, making scans more efficient and improving diagnostic confidence. This focus on operational efficiency and superior image quality is a major purchasing criterion for hospitals and diagnostic centers, propelling the market forward.
The region's aging population is also a significant long-term driver. With a large and growing number of elderly individuals, there is a corresponding rise in age-related conditions requiring regular diagnostic imaging. Furthermore, government initiatives aimed at modernizing healthcare infrastructure and promoting digital health are creating a favorable environment for investment in new medical technologies. The trend toward outpatient and mobile imaging services is also gaining traction, expanding access to MRI services beyond traditional hospital settings
Based on country, the Western Europe magnetic resonance imaging (MRI) systems market is segmented into Belgium, the Netherlands, Luxembourg, Germany, France, Italy, Spain, Switzerland, Sweden, Austria, the United Kingdom, Denmark, Portugal, Norway, and Finland. Germany held the largest share in 2024.
Germany dominates the European MRI systems market, supported by its advanced healthcare infrastructure, high healthcare expenditure, and strong presence of leading medical technology companies such as Siemens Healthineers and Bruker. The country has a robust network of hospitals, diagnostic imaging centers, and research institutes that consistently invest in state-of-the-art MRI systems, including high-field and ultra-high-field scanners.
Increasing prevalence of chronic diseases, including neurological disorders, cancer, and cardiovascular conditions, is driving the demand for accurate and early diagnosis, further boosting MRI adoption. Germany also benefits from supportive government policies, favorable reimbursement frameworks, and initiatives promoting healthcare innovation and medical research. Integration of artificial intelligence and hybrid imaging technologies, such as PET/MRI, is enhancing imaging efficiency and diagnostic accuracy, encouraging further deployment of MRI systems. Overall, Germany’s combination of technological expertise, research focus, and strong healthcare infrastructure makes it the most mature and influential market for MRI systems in Western Europe.
Western Europe Magnetic Resonance Imaging (MRI) Systems Market Company Profiles
GE HealthCare, Siemens Healthineers AG, FUJIFILM Holdings Corporation, Canon Inc., Koninklijke Philips N.V., HYPERFINE, INC., Esaote SPA, Shanghai United Imaging Healthcare Co., LTD, FONAR Corp., and Neusoft Medical Systems are among the key players operating in the market. These players adopt strategies such as expansion, product innovation, and mergers and acquisitions to stay competitive in the market and offer innovative products to their consumers.
The following methodology has been followed for the collection and analysis of data presented in this report:
The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.
Business Market Insights conducts a significant number of primary interviews each year with industry stakeholders and experts to validate and analyze the data and gain valuable insights. These research interviews are designed to:
Primary research is conducted via email interactions and telephone interviews with industry experts across various markets, categories, segments, and sub-segments in different regions. Participants typically include: